Tretinoin: all 143 studies that test it
Page 1 of 2. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of EpendymomaNot yet recruitingNCT07848568Phase 1/2
- Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceNot yet recruitingNCT07842887Phase 1
- All-Trans Retinoic Acid for the Treatment of Hemophagocytic LymphohistiocytosisNot yet recruitingNCT07626398Phase 2/3
- ATRA for Management of Primary ITPNot yet recruitingNCT07597395Phase 3
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingNCT07586813Phase 2
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruitingNCT07504458Phase 3
- ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.Not yet recruitingNCT07348107Phase 1
- Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune ThrombocytopeniaNot yet recruitingNCT07278908Phase 2/3
- Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication SyndromeNot yet recruitingNCT07079696Phase 2
- Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid LeukemiaNot yet recruitingNCT06841952Not applicable
- Reverse HER2-negative Immune Resistant Breast CancerRecruitingNCT06731140Phase 2
- Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck CarcinomaRecruitingNCT06706401Phase 3
- Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06703047Phase 2
- ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCTNot yet recruitingNCT06646666Phase 2
- All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II TrialRecruitingNCT06636981Phase 2
- ATRA and Carfilzomib in Plasma Cell Myeloma PatientsRecruitingNCT06536413Phase 1/2
- Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced LeiomyosarcomaRecruitingNCT06528769Phase 2
- A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHLRecruitingNCT06484920Phase 2
- Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid CancerRecruitingNCT06439888Phase 1/2
- Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid TumorsRecruitingNCT06358677Phase 2
- Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APLRecruitingNCT05497310Phase 1/2
- All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant GliomaRecruitingNCT05345002Phase 2
- Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid LeukemiaEnrolling by invitationNCT03031249Phase 1/2
- Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic LeukemiaRecruitingNCT01409161Phase 2
- Profiling the Skin Microbiome in Response to Altreno in Acne PatientsCompletedNCT04548349Phase 4Results posted
- A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic CarcinomaCompletedNCT03999684Phase 2Results posted
- PHNA, Efficacy of Tretinoin Cream on Post-phototherapy HyperpigmentationCompletedNCT03933774Not applicableResults posted
- A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local TreatmentCompletedNCT03572387Phase 2Results posted
- Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle NeogenesisCompletedNCT03491267Early Phase 1Results posted
- An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing CholangitisTerminatedNCT03359174Phase 2Results posted
- Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaCompletedNCT03200847Phase 1/2Results posted
- A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)CompletedNCT02842827Phase 1/2Results posted
- Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic LeukemiaActive, not recruitingNCT02339740Phase 3Results posted
- Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin GelCompletedNCT02249767Phase 3Results posted
- Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission TherapyCompletedNCT01404949Phase 2Results posted
- A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment ProductsCompletedNCT01313728Phase 4Results posted
- Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and WrinklesCompletedNCT01283464Phase 2Results posted
- Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and PlaceboCompletedNCT01243450Phase 3Results posted
- Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and PlaceboCompletedNCT01135069Phase 3Results posted
- Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch MarksCompletedNCT01027793Phase 4Results posted
- Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the FaceCompletedNCT00919191Phase 4Results posted
- A Study of Acne Treatment in Children Ages 9 to 11CompletedNCT00907335Phase 2Results posted
- A Study of Different Use Regimens Using Two Acne TreatmentsCompletedNCT00907257Phase 4Results posted
- Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne VulgarisCompletedNCT00835198Phase 4Results posted
- Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.CompletedNCT00714714Phase 4Results posted
- Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of PhotodamageCompletedNCT00647556Phase 3Results posted
- To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic AcidCompletedNCT00617409Phase 2Results posted
- Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung CancerCompletedNCT00601796Phase 2Results posted
- Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic LeukemiaTerminatedNCT00528450Phase 2Results posted
- S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00492856Phase 3Results posted
- PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDSCompletedNCT00439673Phase 2Results posted
- Decitabine and Tretinoin in Treating Patients With Myelodysplastic SyndromesCompletedNCT00382200Phase 1/2Results posted
- Phase II 5-Azacytidine Plus VPA Plus ATRACompletedNCT00326170Phase 2Results posted
- Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney CancerCompletedNCT00003656Phase 2Results posted
- Randomized Split-Face Controlled Study to Evaluate the Effectiveness of Topical Eflornithine 9.58% + Hydroquinone 4% + Fluocinolone 0.01% as Compared to Topical Tretinoin 0.05% + Hydroquinone 4% + Fluocinolone 0.01% for the Treatment of MelasmaCompletedNCT07876323Phase 2
- Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic LeukemiaActive, not recruitingNCT07187505Not applicable
- Evaluation of Tretinoin Cream on the Integrity of Aged Forearm SkinCompletedNCT07084116Phase 2/3
- Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-VCompletedNCT07015931Phase 1/2
- Treatment of Plane Warts With Topical and Oral RetinoidsCompletedNCT07012811Phase 4
- Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin MicrobiomeActive, not recruitingNCT06787222Phase 2/3
- The Efficacy Tretinoin Cream in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis NigricansCompletedNCT06213987Phase 3
- Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal CancerActive, not recruitingNCT05999812Phase 2
- Nivolumab and All-trans Retinoic Acid for Pancreatic CancerStatus unknownNCT05482451Early Phase 1
- Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid AcidStatus unknownNCT05297123Phase 1
- A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication SyndromeStatus unknownNCT05281965Early Phase 1
- Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDSStatus unknownNCT05175508Phase 2/3
- Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin CreamStatus unknownNCT05004909Not applicable
- All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung CancerCompletedNCT04919369Phase 1
- A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne VulgarisCompletedNCT04724473Early Phase 1
- A Study of ATRA in the Treatment of ITPStatus unknownNCT04618328Phase 2
- All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT04433169Phase 2
- Opsin Receptors in MelasmaCompletedNCT04417348Not applicable
- Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)CompletedNCT04305054Phase 1/2
- A Study of TAS1440 With ATRA in Subjects With r/r AMLTerminatedNCT04282668Phase 1
- A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic CancerActive, not recruitingNCT04241276Phase 2
- The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT04217148Phase 2
- Altreno for Chest RejuvenationStatus unknownNCT04096742Phase 4
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic LeukaemiaStatus unknownNCT03624270Phase 2
- To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne VulgarisCompletedNCT03433378Early Phase 1
- To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne VulgarisCompletedNCT03427554Early Phase 1
- DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.CompletedNCT03392623Early Phase 1
- Stromal TARgeting for PAncreatic Cancer (STAR_PAC)CompletedNCT03307148Phase 1
- The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03304288Phase 2
- Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AMLTerminatedNCT02942758Phase 2
- Daratumumab in Combination With ATRACompletedNCT02751255Phase 1/2
- Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)Status unknownNCT02717884Phase 1/2
- De Novo Lipogenesis of Sebaceous Glands in AcneCompletedNCT02620813Early Phase 1
- Retinoic Acid Supplementation and Subjects With HypercholesterolemiaCompletedNCT02497833Early Phase 1
- Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging TechnologiesCompletedNCT02410980Early Phase 1
- ATRA, Celecoxib, and Itraconazole as MaintenanceCompletedNCT02401295Phase 1
- Study of TCP-ATRA for Adult Patients With AML and MDSCompletedNCT02273102Phase 1
- Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is PossibleStatus unknownNCT02261779Phase 1/2
- Clinical Guidelines for APL TreatmentStatus unknownNCT02020161Phase 4
- Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APLStatus unknownNCT01987297Phase 4
- All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)WithdrawnNCT01882127Phase 3
- Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01820624Phase 1
- The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT01667263Phase 2
- Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing CholangitisCompletedNCT01456468Phase 1